Mayne Pharma Recalls Fabior Foam Due to Stability Test Failures
Mayne Pharma is recalling 3,312 cans of Fabior (tazarotene) Foam, 0.1%, because stability testing showed high out-of-specification results for the active ingredient.
- Product
- FABIOR — FABIOR (TAZAROTENE)
- Category
- Drug
- Distribution
- Distributed nationwide